Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Hommes

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Analytical and Bioanalytical Chemistry|July 10, 2013
A rapid assay for on-site monitoring of infliximab trough levels: a feasibility studyPaul L A M Corstjens, Herma H Fidder, Karien C Wiesmeijer, et al.
Journal of Crohn'S & Colitis|December 28, 2016
Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional TherapyGeert D'Haens, Walter Reinisch, Jean-Frederic Colombel, et al.
European Journal of Gastroenterology & Hepatology|August 11, 2018
Standardization of mesenchymal stromal cell therapy for perianal fistulizing Crohn's diseaseIlse Molendijk, Andrea E van der Meulen-de Jong, Hein W Verspaget, et al.
Journal of Crohn'S & Colitis|November 26, 2011
Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn's diseaseDaniel W Hommes, Marjolijn Duijvestein, Zuzana Zelinkova, et al.
Immunity|October 9, 2007
Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cellsAstrid J van Beelen, Zuzana Zelinkova, Esther W Taanman-Kueter, et al.
Inflammatory Bowel Diseases|July 17, 2015
Predicting Endoscopic Disease Activity in Crohn's Disease: A New and Validated Noninvasive Disease Activity Index (The Utrecht Activity Index)Itta M Minderhoud, Ewout W Steyerberg, Ad A van Bodegraven, et al.
Gastroenterology|February 29, 2012
Autophagy attenuates the adaptive immune response by destabilizing the immunologic synapseManon E Wildenberg, Anne Christine W Vos, Simone C S Wolfkamp, et al.
Journal of Crohn'S & Colitis|February 6, 2018
Long-term Outcome of Early Combined Immunosuppression Versus Conventional Management in Newly Diagnosed Crohn's DiseaseDaniël R Hoekman, Judith A Stibbe, Filip J Baert, et al.
Inflammatory Bowel Diseases|June 13, 2015
Presenteeism in Inflammatory Bowel Diseases: A Hidden Problem with Significant Economic ImpactAria Zand, Welmoed K van Deen, Elizabeth K Inserra, et al.
European Journal of Gastroenterology & Hepatology|June 25, 2016
Employment status, difficulties at work and quality of life in inflammatory bowel disease patientsAngela G E M De Boer, Floor Bennebroek Evertsz', Pieter C Stokkers, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Analytical and Bioanalytical Chemistry|July 10, 2013
A rapid assay for on-site monitoring of infliximab trough levels: a feasibility studyPaul L A M Corstjens, Herma H Fidder, Karien C Wiesmeijer, et al.
Journal of Crohn'S & Colitis|December 28, 2016
Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional TherapyGeert D'Haens, Walter Reinisch, Jean-Frederic Colombel, et al.
European Journal of Gastroenterology & Hepatology|August 11, 2018
Standardization of mesenchymal stromal cell therapy for perianal fistulizing Crohn's diseaseIlse Molendijk, Andrea E van der Meulen-de Jong, Hein W Verspaget, et al.
Journal of Crohn'S & Colitis|November 26, 2011
Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn's diseaseDaniel W Hommes, Marjolijn Duijvestein, Zuzana Zelinkova, et al.
Immunity|October 9, 2007
Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cellsAstrid J van Beelen, Zuzana Zelinkova, Esther W Taanman-Kueter, et al.
Inflammatory Bowel Diseases|July 17, 2015
Predicting Endoscopic Disease Activity in Crohn's Disease: A New and Validated Noninvasive Disease Activity Index (The Utrecht Activity Index)Itta M Minderhoud, Ewout W Steyerberg, Ad A van Bodegraven, et al.
Gastroenterology|February 29, 2012
Autophagy attenuates the adaptive immune response by destabilizing the immunologic synapseManon E Wildenberg, Anne Christine W Vos, Simone C S Wolfkamp, et al.
Journal of Crohn'S & Colitis|February 6, 2018
Long-term Outcome of Early Combined Immunosuppression Versus Conventional Management in Newly Diagnosed Crohn's DiseaseDaniël R Hoekman, Judith A Stibbe, Filip J Baert, et al.
Inflammatory Bowel Diseases|June 13, 2015
Presenteeism in Inflammatory Bowel Diseases: A Hidden Problem with Significant Economic ImpactAria Zand, Welmoed K van Deen, Elizabeth K Inserra, et al.
European Journal of Gastroenterology & Hepatology|June 25, 2016
Employment status, difficulties at work and quality of life in inflammatory bowel disease patientsAngela G E M De Boer, Floor Bennebroek Evertsz', Pieter C Stokkers, et al.
Pageof 13